Jason Cota – PESI – Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians

Description

Jason Cota – PESI – Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians download, Jason Cota – PESI – Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians review, Jason Cota – PESI – Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians free

Jason Cota – PESI – Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians

In this recording, you’ll learn proper prescribing, patient education and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases. Choosing an antibacterial agent can be challenging, given the plethora of drugs available on the market and the emerging trend in bacterial resistance.

You will learn the pharmacology of different classes of antimicrobials used to treat infectious disease states encountered in clinical practice. Discover the spectrums of activity, pharmacokinetic characteristics and parameters for monitoring therapeutic outcomes. Emphasis is placed on the new antimicrobials and advances in evidence-based treatment guidelines. After watching, you will be better prepared to design appropriate and cost-effective drug regimens for improved therapeutic outcomes.

Speaker

Jason Cota, PharmD, MS
Jason Cota, PharmD, MS, is an associate professor and the vice chair of the pharmacy practice department at the University of the Incarnate Word Feik School of Pharmacy. He has over 10 years of experience practicing as an infectious diseases clinical pharmacist at the San Antonio Military Medical Center, where he is a credentialed provider with prescriptive authority.

Dr. Cota completed a two-year Specialty Practice Residency in Pharmacotherapy at The University of Texas Health Science Center at San Antonio with an emphasis in both infectious diseases and nephrology. He is a member of the Society of Infectious Diseases Pharmacists and has given several presentations at national and international meetings. His research has focused on antimicrobial and antifungal drug dosing in patient populations that are subject to altered pharmacokinetics.

Speaker Disclosures:

Financial: Jason Cota is vice chair and associate professor at the University of the Incarnate Word Feik School of Pharmacy. He receives a speaking honorarium from Merck. Dr. Cota receives a speaking honorarium for PESI, Inc.

Non-financial: Jason Cota is a member of the Society of Infectious Diseases Pharmacists.

Objectives

1. Analyze the major classes of antibiotics and their pharmacokinetic characteristics.
2. Apply current evidenced-based approaches to select appropriate treatment regimens for common infections encountered in clinical practice.
3. Prescribe antimicrobials based on empiric dosing recommendations.
4. Plan goals of therapy and parameters for monitoring therapeutic response to antimicrobials.
5. Recommend specific antimicrobial therapeutic drug monitoring to maximize efficacy and minimize toxicities (e.g., vancomycin and aminoglycosides).
6. Develop preventative strategies to limit antimicrobial resistance.
7. Design patient and caregiver education on the proper use of antimicrobials.

Outline

Antimicrobials

• Drug classes
• Pharmacokinetic Properties
  • Concentration-dependent killing
  • Time-dependent killing
  • Post-antibiotic effect
• Common interactions with other drugs

Antibacterial Allergies – Sulfa and Penicillin

• Define true allergy
• Sulfonamide antibiotics vs non-antibiotics
• Penicillin – Cephalosporin cross-sensitivity

Bacteria

• Differentiation
• Normal flora
• Common pathogens

Antibacterial Resistance – Contributing Factors

• Trends
• Mechanisms of resistance
• Contributing factors

Methicillin-Resistant Staphylococcus Aureus – Community versus Hospital Acquired

• Differentiating between CA- and HA-MRSA
• Current clinical practice guidelines
• Pharmacologic management

Enterobacteriaceae Resistance

• Extended Spectrum Beta-Lactamase (ESBL)
  • What are ESBLs
  • Pharmacologic management
• Carbapenem-Resistant Enterobacteriaceae (CRE)
  • What are CREs
  • Pharmacologic management

Urinary Tract Infections

• Bacterial Etiology, Signs and Symptoms and Diagnosis
• Cystitis and pyelonephritis
• Complicated and uncomplicated
• UTIs in pregnancy
• Treatment (IDSA Guideline Treatment Algorithm)
  • Acute
  • Recurrent and relapse

Clostridium Difficile Infection

• Risk factors
• Pharmacology management
• Fecal Transplantation
• Probiotics literature review

Community–Acquired Pneumonia

• Bacterial etiology
• Diagnosis
• Typical vs. atypical
• Treatment (IDSA/ATS Guidelines) and monitoring
  • Outpatient vs. inpatient
  • Empiric treatment

Healthcare–Associated Pneumonia

• Bacterial etiology
• Treatment (IDSA/ATS Guidelines)
• Treatment Controversy

Upper Respiratory Tract Infections

• Sinusitis and pharyngitis
  • Etiology (Viral vs. Bacterial)
  • Treatment
• Bronchitis and Pertussis
  • Etiology (Viral vs. Bacterial)
  • Treatment

Skin and Soft Tissue Infections

• Cellulitis
• Diabetic foot infections
• Bacterial etiology
  • Signs & symptoms
  • Treatment (IDSA Guidelines)
• Osteomyelitis
  • Acute vs. Chronic
  • Oral considerations

Strategies to Improve Patient Adherence

• IMS Model (Information-Motivation-Strategy)
• Major predictors of poor adherence to medication

Antibacterial Resistance – Prevention Strategies

• Mechanisms for drug resistance
• 12 steps to prevent antimicrobial resistance (CDC)
• Antibiotic stewardship

Emerging and Reemerging Viral Infections

• Animals as sources
• Drivers and ecological factors
• Modes of transmission
• Pharmacology management

Influenza

• Clinical features
• Diagnosis
• Pharmacology management

Immunizations (Adult)

• Types of Vaccines
• General recommendations
• Contraindications & precautions

Target Audience

• Nurses
• Advanced Practice Nurses
• Clinical Nurse Specialists
• Pharmacists
• Nurse Practitioners
• Physician Assistants

Reviews

Melissa F
“Great course, great presenter”

Lindsay H
“The speaker was great! He made the presentation interesting and engaging”

Frequently Asked Questions:

1. Innovative Business Model:
   • Embrace the reality of a genuine business! Our approach involves forming a group buy, where we collectively share the costs among members. Using these funds, we purchase sought-after courses from sale pages and make them accessible to individuals facing financial constraints. Despite potential reservations from the authors, our customers appreciate the affordability and accessibility we provide.
2. The Legal Landscape: Yes and No:
   • The legality of our operations falls into a gray area. While we lack explicit approval from the course authors for resale, there’s a technicality at play. When procuring the course, the author didn’t specify any restrictions on resale. This legal nuance presents both an opportunity for us and a boon for those seeking budget-friendly access.
3. Quality Assurance: Unveiling the Real Deal:
   • Delving into the heart of the matter – quality. Acquiring the course directly from the sale page ensures that all documents and materials are identical to those obtained through conventional means. However, our differentiator lies in going beyond personal study; we take an extra step by reselling. It’s important to note that we are not the official course providers, meaning certain premium services aren’t included in our package:
     • No coaching calls or scheduled sessions with the author.
     • No access to the author’s private Facebook group or web portal.
     • No entry to the author’s exclusive membership forum.
     • No direct email support from the author or their team.

   We operate independently, aiming to bridge the affordability gap without the additional services offered by official course channels. Your understanding of our unique approach is greatly appreciated.

Refund is acceptable:

• Firstly, item is not as explained
• Secondly, Item do not work the way it should.
• Thirdly, and most importantly, support extension can not be used.

Thank you for choosing us! We’re so happy that you feel comfortable enough with us to forward your business here.